Search Results 641-650 of 19211 for hemoglobin

  1. Ravulizumab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    * Uncontrolled diabetes mellitus with glycosylated hemoglobin (HbA1c) \> 8.5%. * Clinically active Henoch-Schonlein purpura (IgA vasculitis) requiring ...

  2. Hyperbaric oxygen therapy - Mayo Clinic

    This type of therapy is a well-known treatment for decompression sickness, but it has other uses. Find out about why and how oxygen may help heal the body.

  3. Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants - Mayo Clinic

    Have glycosylated hemoglobin (HbA1c) greater than (>) 12 percent (%). Have other structural diseases/conditions that affect the gastrointestinal (GI) system ...

  4. Anticoagulation in ICH Survivors for Stroke Prevention and Recovery - Mayo Clinic

    Anemia (hemoglobin < 8 g/dL) or thrombocytopenia (< 100 x 10^9/L) that is chronic in the judgment of the investigator. Pregnant or breastfeeding. Known ...

  5. Arteriosclerosis / atherosclerosis - Doctors and departments - Mayo Clinic

    Mayo Clinic cardiologists, cardiovascular surgeons and others perform clinical research to develop new treatments and approaches to reduce the risk of heart ...

  6. Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable); Total bilirubin < 2 x ...

  7. Auranofin and Sirolimus in Treating Participants With Ovarian Cancer - Mayo Clinic

    Obtained =< 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dL; Obtained =< 14 days prior to registration: Total bilirubin =< 1.5 x upper limit of ...

  8. Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1 - Mayo Clinic

    Able to swallow whole capsules [Pending availability of granule formulation]. 6. Hematologic Function: Absolute neutrophil count ≥ 1200/µL, hemoglobin ≥ 9g/dL ...

  9. A Study to Evaluate the Safety and Effectiveness of MOR202 in Anti-PLA2R Antibody-positive Membranous Nephropathy - Mayo Clinic

    Participation eligibility · Hemoglobin* < 90 g/L; · Thrombocytopenia**:. Platelets < 100.0 x 10^9 /L; · Neutropenia***: Neutrophils < 1.5 x 10^9 /L; · Leukopenia*** ...

  10. PKCι & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9 g/dL; Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or direct bilirubin ≤ ULN; Serum glutamic oxaloacetic transaminase (SGOT) ...